Paul Tudor Jones Guardant Health, Inc. Transaction History
Tudor Investment Corp Et Al
- $19.2 Billion
- Q2 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 239,223 shares of GH stock, worth $5.44 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
239,223Holding current value
$5.44 Million% of portfolio
0.04%Shares
15 transactions
Others Institutions Holding GH
# of Institutions
331Shares Held
116MCall Options Held
680KPut Options Held
1.66M-
Vanguard Group Inc Valley Forge, PA11.6MShares$265 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$255 Million0.01% of portfolio
-
Baillie Gifford & CO6.09MShares$139 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$102 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$102 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.32B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...